Discover
FBIO
Fortress Biotech, Inc.
2.93
2 x 2.90
20 x 3.00
bid
ask
-
0.05
1.68%
1000 @ 04:00 PM
2.98 +0.05 (1.61%)
| Ytd | -19.95% | |
| 1y | 49.49% |
2.71
day range
2.95
1.96
52 week range
4.38
| Open | 2.83 | Prev Close | 2.98 | Low | 2.71 | High | 2.95 | Mkt Cap | 97.33M |
| Vol | 1.03M | Avg Vol | 603.98K | EPS | 2.26 | P/E | 1.30 | Forward P/E | -0.99 |
| Beta | 1.75 | Short Ratio | 4.57 | Inst. Own | 15.78% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 3.05 | 200-d Avg | 2.99 | 1yr Est | 14.33 |
FBIO News
globenewswire.com
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Total net revenue increased 14% to $18.7 million for second quarter of 2026 compared to second quart
seekingalpha.com
Fortress Biotech, Inc. (FBIO) Q2 2026 Earnings Call Transcript
Fortress Biotech, Inc. (FBIO) Q2 2026 Earnings Call Transcript
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Universe Pharmaceuticals (NASDAQ:UPC) shares increased by 108.5% to $6.59 during Monday'
benzinga.com
Fortress Biotech’s Urica Therapeutics Says Crystalys Closes Oversubscribed $130M Series B Financing
Urica Therapeutics, Inc. ("Urica" or the "Company"), a Fortress Biotech, Inc. (NASDA